---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-107434"
form_type: "8-K"
ticker: "COCH"
cik: "0001840877"
company_name: "Envoy Medical, Inc."
filed_at: "2026-10-07T13:00:14+00:00"
generated_at: "2026-10-12T15:58:15.532701+00:00"
event_type: "litigation"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Envoy Medical settles Atlas SPAC redemption suit; all claims dismissed with prejudice, no payment owed

## Summary
- Envoy Medical entered a Dismissal Agreement on October 6, 2026 ending Delaware Court of Chancery litigation brought by Atlas Merchant Capital SPAC Fund I LP.
- Atlas had alleged it was not allowed to redeem its Class A Common Stock in the Company's September 2023 business combination transaction.
- All of Atlas' claims will be dismissed with prejudice and no further proceedings will occur in the Litigation.
- Neither Envoy Medical nor any other defendant is required to make any payment to Atlas under the Dismissal Agreement.
- 8-K signed October 7, 2026 by CEO Brent Lucas; Exhibit 104 cover page XBRL only, no financial statements filed.

## SEC filing metadata
- accession: 0001213900-26-107434
- form_type: 8-K
- ticker: COCH
- cik: 0001840877
- company_name: Envoy Medical, Inc.
- filed_at: 2026-10-07T13:00:14+00:00
- event_type: litigation
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840877/000121390026107434/0001213900-26-107434-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840877/000121390026107434/ea0307906-8k_envoy.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-107434
- JSON: https://secwatch.observer/filing/0001213900-26-107434.json
- Plain text: https://secwatch.observer/filing/0001213900-26-107434.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.